Support Texas Flood Recovery Efforts

brand logo

Am Fam Physician. 2025;111(6):496-497

This clinical content conforms to AAFP criteria for CME.

Author disclosure: No relevant financial relationships.

CLINICAL QUESTION

Do educational interventions improve the likelihood that health care professionals will report adverse drug reactions?

EVIDENCE-BASED ANSWER

When combined with adverse drug reaction reporting forms and reminder cards, educational interventions improve the overall reporting rate by health care professionals compared with standard spontaneous reporting (risk ratio [RR] = 3.00; 95% CI, 1.53–5.90; five studies; n = 21,655).1 (Strength of Recommendation [SOR]: C, based on disease-oriented evidence.) Improving hospital-based health care professionals' access to standardized adverse drug reaction reporting forms at the time of patient discharge improves the number of reports submitted (RR = 2.06; 95% CI, 1.11–3.83). (SOR: C, based on disease-oriented evidence.) Most educational interventions in isolation, such as sending informational letters or emails to health care professionals, do not affect the number of reports submitted.

PRACTICE POINTERS

Adverse drug events, including adverse drug reactions and drug errors, are estimated to be among the most common causes of death worldwide.1,2 Although some adverse drug reactions are detected during clinical trials, many remain unknown and require strong pharmacovigilance by health care professionals to identify and report adverse reactions to prevent or minimize further potential harm.3,4 Spontaneous or voluntary reporting of adverse drug reactions by health care professionals is considered standard practice, yet adverse drug reactions remain underreported.3,4 Depending on the type and severity of adverse drug reaction, estimates suggest that up to 94% of events are not reported.3,4 Reports to the US Food and Drug Administration (FDA) must at minimum include the drug name, description of the event, and name of the reporter. Various educational and promotional activities have been implemented to improve adverse drug reaction reporting rates, including informational initiatives, financial incentives, governmental regulations, and process improvement efforts enhancing access to report forms or increasing reporting options.1

Already a member/subscriber?  Log In

Subscribe

From $165
  • Immediate, unlimited access to all AFP content
  • More than 130 CME credits/year
  • AAFP app access
  • Print delivery available
Subscribe

Issue Access

$59.95
  • Immediate, unlimited access to this issue's content
  • CME credits
  • AAFP app access
  • Print delivery available
Purchase Access:  Learn More

These are summaries of reviews from the Cochrane Library.

This series is coordinated by Corey D. Fogleman, MD, assistant medical editor.

A collection of Cochrane for Clinicians published in AFP is available at https://www.aafp.org/afp/cochrane.

Continue Reading

More in AFP

More in PubMed

Copyright © 2025 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP.  See permissions for copyright questions and/or permission requests.